Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion
-
Published:2023-06-19
Issue:6
Volume:11
Page:1761
-
ISSN:2227-9059
-
Container-title:Biomedicines
-
language:en
-
Short-container-title:Biomedicines
Author:
Lucarini Valeria1, Nardozi Daniela2ORCID, Angiolini Valentina1ORCID, Benvenuto Monica23ORCID, Focaccetti Chiara2ORCID, Carrano Raffaele2, Besharat Zein Mersini1ORCID, Bei Roberto2ORCID, Masuelli Laura1
Affiliation:
1. Department of Experimental Medicine, University of Rome “Sapienza”, Viale Regina Elena 324, 00161 Rome, Italy 2. Department of Clinical Sciences and Translational Medicine, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy 3. Departmental Faculty of Medicine and Surgery, Saint Camillus International University of Health and Medical Sciences, via di Sant’Alessandro 8, 00131 Rome, Italy
Abstract
Gastrointestinal (GI) cancers are the most frequent neoplasm, responsible for half of all cancer-related deaths. Metastasis is the leading cause of death from GI cancer; thus, studying the processes that regulate cancer cell migration is of paramount importance for the development of new therapeutic strategies. In this review, we summarize the mechanisms adopted by cancer cells to promote cell migration and the subsequent metastasis formation by highlighting the key role that tumor microenvironment components play in deregulating cellular pathways involved in these processes. We, therefore, provide an overview of the role of different microRNAs in promoting tumor metastasis and their role as potential biomarkers for the prognosis, monitoring, and diagnosis of GI cancer patients. Finally, we relate the possible use of nutraceuticals as a new strategy for targeting numerous microRNAs and different pathways involved in GI tumor invasiveness.
Funder
Ministero della Salute Progetto Ateneo Sapienza 2021 Ministero dell’Università e della Ricerca, PRIN 2020
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference312 articles.
1. Losurdo, P., de Manzini, N., Palmisano, S., Grassi, M., Parisi, S., Rizzolio, F., Tierno, D., Biasin, A., Grassi, C., and Truong, N.H. (2022). Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors. Pharmaceuticals, 15. 2. Global Burden of 5 Major Types of Gastrointestinal Cancer;Arnold;Gastroenterology,2020 3. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications;Wang;Front. Immunol.,2021 4. Neoadjuvant immunotherapy in gastrointestinal cancers–The new standard of care?;Petricevic;Semin. Cancer Biol.,2022 5. Tan, Z., Sun, W., Li, Y., Jiao, X., Zhu, M., Zhang, J., Qing, C., and Jia, Y. (2022). Current Progress of EMT: A New Direction of Targeted Therapy for Colorectal Cancer with Invasion and Metastasis. Biomolecules, 12.
|
|